16/03/2026
Great conversations, meaningful connections, and a shared vision for the future of biologics manufacturing.
It was a pleasure engaging with industry leaders, partners, and innovators at the 13th Annual Biologics Manufacturing Asia 2026 at the Sands Expo & Convention Centre in Singapore. The energy around the conference clearly reflected how rapidly the biologics ecosystem across Asia is evolving.
A sincere thank you to everyone who took the time to visit our booth. The discussions around bioprocessing challenges, manufacturing scalability, and the future of liquid handling solutions were insightful and reaffirmed the growing need for collaboration between innovators, manufacturers, and technology providers.
A special appreciation to IMAPAC for organizing such a well-curated platform that brings together the biologics manufacturing community across the region.
One theme stood out across many conversations: the changing dynamics between bioprocessing suppliers and consumers. As biologics pipelines expand and manufacturing models evolve, there is an increasing demand for flexible, scalable, and contamination-resilient solutions. This is accelerating the adoption of single-use technologies in liquid handling and biomanufacturing, enabling faster facility deployment, reduced cleaning validation burden, and improved operational agility.
It is an exciting time for the industry, and forums like this play a crucial role in shaping the future of biomanufacturing. Looking forward to continuing these conversations and collectively work toward more efficient, accessible, and resilient biologics manufacturing.
We are looking forward to seeing you at:
@ Booth 03 in Single-Use Event 2026, Basel; March 19, 2026.
@ Stand 1347, INTERPHEX, Javits Center, New York, USA; April 21-23, 2026.
